
Gilimac PM 1mg/500mg/15mg Tablet SR
Marketer
Pride Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Gilimac PM 1mg/500mg/15mg Tablet SR
Combiflex DM, a 1mg/500mg/15mg extended-release tablet, is a triple-combination medication managing blood glucose. Supplementing diet and exercise, it improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, thus reducing blood sugar. Dosage and frequency of Combiflex DM should strictly adhere to your physician's prescription. Ingestion with food mitigates gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; in such cases, omit the missed dose and resume the regular schedule. Never double the dose; overdose can cause hypoglycemia. Concurrent use with other antidiabetics, alcohol consumption, or skipped meals raises the hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and upper respiratory infections. Pre-existing kidney, liver, or heart conditions necessitate prior physician consultation. This is also essential for pregnant or lactating individuals. Renal function tests are conducted before initiating treatment. Limiting alcohol consumption is advised to minimize potential side effects.
Uses of Gilimac PM 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Gilimac PM 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Gilimac PM 1mg/500mg/15mg Extended-Release Tablet should be administered with a meal.
Common Side effects of Gilimac PM 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Gilimac PM 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gilimac PM 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
How Gilimac PM 1mg/500mg/15mg Tablet SR works:
Gilimac PM 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach improves blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further augments insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Gilimac PM 1mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Gilimac PM 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks before prescribing this medication. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Gilimac PM tablets (1mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Gilimac PM 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Gilimac PM 1mg/500mg/15mg SR tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Gilimac PM 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is essential. The use of Gilimac PM 1mg/500mg/15mg Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Gilimac PM 1mg/500mg/15mg Tablet SR :
Should you forget a dose of Gilimac PM 1mg/500mg/15mg SR Tablet, take it immediately if you remember. If your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Gilimac PM 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
